|
|
|
| This article has been cited by | | 1 | Medicinal Cannabis and Central Nervous System Disorders | | | Yuma T. Ortiz,Lance R. McMahon,Jenny L. Wilkerson | | Frontiers in Pharmacology.2022;13() | | [DOI] | | | 2 | The Impact of Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis | | | Jiantao Zhao,Xuemei Wang,Zijun Huo,Yanchun Chen,Jinmeng Liu,Zhenhan Zhao,Fandi Meng,Qi Su,Weiwei Bao,Lingyun Zhang,Shuang Wen,Xin Wang,Huancai Liu,Shuanhu Zhou | | Cells.2022;11(13)2049 | | [DOI] | | | 3 | Retinal abnormalities in transgenic mice overexpressing aberrant human FUS[1-359] gene | | | VO Soldatov,MS Kukharsky,MO Soldatova,OA Puchenkova,YuA Nikitina,EA Lysikova,NL Kartashkina,AV Deykin,MV Pokrovskiy | | Bulletin of Russian State Medical University.2021;11(2021(4))2049 | | [DOI] | | | 4 | Oxidative Stress as a Therapeutic Target in Amyotrophic Lateral Sclerosis: Opportunities and Limitations | | | Hee Ra Park,Eun Jin Yang | | Diagnostics.2021;11(9)1546 | | [DOI] | |
|
